Related references
Note: Only part of the references are listed.A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-alpha) in patients with systemic lupus erythematosus (ROSE)
Kenneth C. Kalunian et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
The Basis of Oncoimmunology
A. Karolina Palucka et al.
CELL (2016)
Immunoglobulin isotype knowledge and application to Fc engineering
Randall J. Brerski et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
J. M. Michot et al.
EUROPEAN JOURNAL OF CANCER (2016)
TIGIT overexpression diminishes the function of CD4 T cells and ameliorates the severity of rheumatoid arthritis in mouse models
Weigong Zhao et al.
EXPERIMENTAL CELL RESEARCH (2016)
Safety and antitumour activity of durvalumab plus tremelimumab in non-small-cell lung cancer: a multicentre, phase 1b study
Scott Antonia et al.
LANCET ONCOLOGY (2016)
Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease
Christian Lood et al.
NATURE MEDICINE (2016)
The cancer immunogram
Christian U. Blank et al.
SCIENCE (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Clinical Images: Autoimmune arthropathy and uveitis as complications of programmed death 1 inhibitor treatment
Guillermo de Velasco et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
Douglas B. Johnson et al.
JAMA ONCOLOGY (2016)
Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms
Alex Pellerin et al.
EMBO MOLECULAR MEDICINE (2015)
Upholding the T cell immune-regulatory function of CD31 inhibits the formation of T/B immunological synapses in vitro and attenuates the development of experimental autoimmune arthritis in vivo
Marc Clement et al.
JOURNAL OF AUTOIMMUNITY (2015)
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Dirk Schadendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The IL-23-IL-17 axis in inflammatory arthritis
Erik Lubberts
NATURE REVIEWS RHEUMATOLOGY (2015)
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
Emanuela Romano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients
Vanessa Fleischer et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways
Cuiping Liu et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Rapid complete response of metastatic melanoma in a patient undergoing ipilimumab immunotherapy in the setting of active ulcerative colitis
A Doran Bostwick et al.
Journal for ImmunoTherapy of Cancer (2015)
Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma
Ahmad A. Tarhini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice
Jason S. Knight et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Aberrant CD200/CD200R1 expression and its potential role in Th17 cell differentiation, chemotaxis and osteoclastogenesis in rheumatoid arthritis
Yan Ren et al.
RHEUMATOLOGY (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
Daniel J. Wallace et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease
Magnus Pedersen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Do inhibitory immune receptors play a role in the etiology of autoimmune disease?
Marloes J. M. Olde Nordkamp et al.
CLINICAL IMMUNOLOGY (2014)
PILRα Negatively Regulates Mouse Inflammatory Arthritis
Yonglian Sun et al.
JOURNAL OF IMMUNOLOGY (2014)
Ipilimumab in patients with cancer and the management of dermatologic adverse events
Mario E. Lacouture et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease
Jennifer Mueller et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations
Omid Vafa et al.
METHODS (2014)
Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity
Li Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006
Vibeke Strand et al.
RHEUMATOLOGY (2014)
Immune checkpoint receptors in regulating immune reactivity in rheumatic disease
Sabrina Ceeraz et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Efficacy and Safety of Abatacept in Lupus Nephritis A Twelve-Month, Randomized, Double-Blind Study
Richard Furie et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Ipilimumab in patients with melanoma and autoimmune disease
Chrisann Kyi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
CD22 ligation inhibits downstream B cell receptor signaling and Ca2+flux upon activation
N. Sieger et al.
ARTHRITIS AND RHEUMATISM (2013)
Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab
Edmund A. Rossi et al.
BLOOD (2013)
Organizing Pneumonia as a Side Effect of Ipilimumab Treatment of Melanoma
Igor Z. Barjaktarevic et al.
CHEST (2013)
Neutrophil infiltration during inflammation is regulated by PILR alpha via modulation of integrin activation
Jing Wang et al.
NATURE IMMUNOLOGY (2013)
CD200R/CD200 Inhibits Osteoclastogenesis: New Mechanism of Osteoclast Control by Mesenchymal Stem Cells in Human
Audrey Varin et al.
PLOS ONE (2013)
Ligation of Signal Inhibitory Receptor on Leukocytes-1 Suppresses the Release of Neutrophil Extracellular Traps in Systemic Lupus Erythematosus
Kristof Van Avondt et al.
PLOS ONE (2013)
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up
Daniel J. Wallace et al.
RHEUMATOLOGY (2013)
CD200R signaling in tumor tolerance and inflammation: A tricky balance
Tomasz F. Rygiel et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Disease Tolerance as a Defense Strategy
Ruslan Medzhitov et al.
SCIENCE (2012)
CD200 Receptor Controls Sex-Specific TLR7 Responses to Viral Infection
Guruswamy Karnam et al.
PLOS PATHOGENS (2012)
Abatacept in the Treatment of Patients With Psoriatic Arthritis
Philip Mease et al.
ARTHRITIS AND RHEUMATISM (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
An update on an immune system that goes awry in systemic sclerosis
L. van Bon et al.
CURRENT OPINION IN RHEUMATOLOGY (2011)
Vstm3 is a member of the CD28 family and an important modulator of T-cell function
Steven D. Levin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
Li Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Antibody-Mediated Coengagement of FcγRIIb and B Cell Receptor Complex Suppresses Humoral Immunity in Systemic Lupus Erythematosus
Holly M. Horton et al.
JOURNAL OF IMMUNOLOGY (2011)
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
Nicole Joller et al.
JOURNAL OF IMMUNOLOGY (2011)
MECHANISMS OF DISEASE Systemic Lupus Erythematosus
George C. Tsokos
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Genome-Wide Association Analysis of Autoantibody Positivity in Type 1 Diabetes Cases
Vincent Plagnol et al.
PLOS GENETICS (2011)
The Efficacy and Safety of Abatacept in Patients With Non-Life-Threatening Manifestations of Systemic Lupus Erythematosus Results of a Twelve-Month, Multicenter, Exploratory, Phase IIb, Randomized, Double-Blind, Placebo-Controlled Trial
J. T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Immune Inhibitory Ligand CD200 Induction by TLRs and NLRs Limits Macrophage Activation to Protect the Host from Meningococcal Septicemia
Subhankar Mukhopadhyay et al.
CELL HOST & MICROBE (2010)
CD200R1 regulates the severity of arthritis but has minimal impact on the adaptive immune response
E. Simelyte et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Signal Inhibitory Receptor on Leukocytes-1 Is a Novel Functional Inhibitory Immune Receptor Expressed on Human Phagocytes
Tessa A. M. Steevels et al.
JOURNAL OF IMMUNOLOGY (2010)
TCR Stimulation Drives Cleavage and Shedding of the ITIM Receptor CD31
Giulia Fornasa et al.
JOURNAL OF IMMUNOLOGY (2010)
CD200R1 Agonist Attenuates Mechanisms of Chronic Disease in a Murine Model of Multiple Sclerosis
Yingru Liu et al.
JOURNAL OF NEUROSCIENCE (2010)
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
Eli A. Stahl et al.
NATURE GENETICS (2010)
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
Andre Franke et al.
NATURE GENETICS (2010)
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes
Jeffrey C. Barrett et al.
NATURE GENETICS (2009)
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
Xin Yu et al.
NATURE IMMUNOLOGY (2009)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
CD200-Fc, a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis
Egle Simelyte et al.
ARTHRITIS AND RHEUMATISM (2008)
Autoantibodies and Microvascular Damage Are Independent Predictive Factors for the Progression of Raynaud's Phenomenon to Systemic Sclerosis A Twenty-Year Prospective Study of 586 Patients, With Validation of Proposed Criteria for Early Systemic Sclerosis
Martial Koenig et al.
ARTHRITIS AND RHEUMATISM (2008)
Systemic increase in type I interferon activity in Sjogren's syndrome: A putative role for plasmacytoid dendritic cells
Manon E. Wildenberg et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Immunoreceptor tyrosine-based inhibition motifs:: a quest in the past and future
Marc Daeron et al.
IMMUNOLOGICAL REVIEWS (2008)
The soluble leukocyte-associated Ig-like receptor (LAIR)-2 antagonizes the Collagen/LAIR-1 inhibitory immune interaction
Robert Jan Lebbink et al.
JOURNAL OF IMMUNOLOGY (2008)
The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes
Eva S. K. Rijkers et al.
MOLECULAR IMMUNOLOGY (2008)
Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci
Jason D. Cooper et al.
NATURE GENETICS (2008)
Monoclonal anti body-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis
David A. Copland et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity
Manuela Fanciulli et al.
NATURE GENETICS (2007)
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
Ganesh Suntharalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A role for the immunomodulatory molecules CD200 and CD200R in regulating bone formation
L. Lee et al.
IMMUNOLOGY LETTERS (2006)
Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients
FK Tan et al.
RHEUMATOLOGY (2006)
The devil in the details: The emerging role of anticitrulline autoimmunity in rheumatoid arthritis
F van Gaalen et al.
JOURNAL OF IMMUNOLOGY (2005)
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
RV Parry et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions
AM Boruchov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
B-cell depletion inhibits arthritis in a collagen-induced arthritis (CIA) model, but does not adversely affect humoral responses in a respiratory syncytial virus (RSV) vaccination model
K Dunussi-Joannopoulos et al.
BLOOD (2005)
The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis
MX Wong et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2005)
Neutrophil extracellular traps kill bacteria
V Brinkmann et al.
SCIENCE (2004)
Specific autoantibodies precede the symptoms of rheumatoid arthritis - A study of serial measurements in blood donors
MMJ Nielen et al.
ARTHRITIS AND RHEUMATISM (2004)
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation
JM Chemnitz et al.
JOURNAL OF IMMUNOLOGY (2004)
PECAM-1: old friend, new partners
N Ilan et al.
CURRENT OPINION IN CELL BIOLOGY (2003)
Characterization of the CD200 receptor family in mice and humans and their interactions with CD200
GJ Wright et al.
JOURNAL OF IMMUNOLOGY (2003)
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
L Bennett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Acceleration of the onset of collagen-induced arthritis by a deficiency of platelet endothelial cell adhesion molecule 1
Y Tada et al.
ARTHRITIS AND RHEUMATISM (2003)
A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans
L Prokunina et al.
NATURE GENETICS (2002)
Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function
GJ Wright et al.
IMMUNITY (2000)
Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis
S Bolland et al.
IMMUNITY (2000)
FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells
N Fournier et al.
JOURNAL OF IMMUNOLOGY (2000)
PILRα, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRβ
DD Mousseau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
